These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 11376111

  • 1. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J, Saatcioglu F, Jänne OA, Palvimo JJ.
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [Abstract] [Full Text] [Related]

  • 2. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA, Gottlieb B, Lumbroso R, Beitel LK, Elhaji Y, Wu J, Pinsky L, Trifiro MA.
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA, Stoica I, Dennis S, Purisima EO, Lumbroso R, Beitel LK, Trifiro MA.
    Hum Mol Genet; 2006 Mar 15; 15(6):921-31. PubMed ID: 16449235
    [Abstract] [Full Text] [Related]

  • 6. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL, Tut TG, Ghadessy FJ, Prins G, Ratnam SS.
    Mol Cell Endocrinol; 1998 Feb 15; 137(1):41-50. PubMed ID: 9607727
    [Abstract] [Full Text] [Related]

  • 7. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A, Jääskeläinen J, Dattani M, Whitaker HC, Costigan C, Hughes IA.
    J Clin Endocrinol Metab; 2008 Oct 15; 93(10):3691-6. PubMed ID: 18697867
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
    Elhaji YA, Wu JH, Gottlieb B, Beitel LK, Alvarado C, Batist G, Trifiro MA.
    Mol Endocrinol; 2004 Aug 15; 18(8):1876-86. PubMed ID: 15118070
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R, Bunch T, Schwabe JW, Hughes IA, Murphy JC.
    Clin Endocrinol (Oxf); 2009 Aug 15; 71(2):253-60. PubMed ID: 19178528
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
    Slagsvold T, Kraus I, Bentzen T, Palvimo J, Saatcioglu F.
    Mol Endocrinol; 2000 Oct 15; 14(10):1603-17. PubMed ID: 11043576
    [Abstract] [Full Text] [Related]

  • 12. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D, Steinberg SV, Rouault E, Chagnon S, Gottlieb B, Pinsky L, Trifiro M, Mader S.
    Mol Endocrinol; 2001 Oct 15; 15(10):1790-802. PubMed ID: 11579211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
    Jääskeläinen J, Mongan NP, Harland S, Hughes IA.
    Hum Mutat; 2006 Mar 15; 27(3):291. PubMed ID: 16470553
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM, Werner R, Struve D, Hauffa BP, Schroeder C, Hiort O.
    Exp Clin Endocrinol Diabetes; 2005 Sep 15; 113(8):457-63. PubMed ID: 16151980
    [Abstract] [Full Text] [Related]

  • 17. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions.
    Black BE, Vitto MJ, Gioeli D, Spencer A, Afshar N, Conaway MR, Weber MJ, Paschal BM.
    Mol Endocrinol; 2004 Apr 15; 18(4):834-50. PubMed ID: 14684849
    [Abstract] [Full Text] [Related]

  • 18. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY, Hoogerbrugge JW, Pang KL, van Leeuwen M, van Royen ME, Molier M, Berrevoets CA, Dooijes D, Dubbink HJ, van de Wijngaart DJ, Wolffenbuttel KP, Trapman J, Kleijer WJ, Drop SL, Grootegoed JA, Brinkmann AO.
    Mol Cell Endocrinol; 2008 Sep 24; 292(1-2):69-78. PubMed ID: 18656523
    [Abstract] [Full Text] [Related]

  • 19. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, Brinkmann AO, Trapman J.
    Biochemistry; 1997 Feb 04; 36(5):1052-64. PubMed ID: 9033395
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.